๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
341 medicines starting with โ€œFโ€
MedicineActive substanceLicence holderStatus
FABHALTA 200 mg hard capsules
EU/1/24/1802/001-003
Iptacopan Novartis Europharm Limited โ€”
Fabrazyme 35 mg powder for concentrate for solution for infusion
EU/1/01/188/001-003
Agalsidase Beta Sanofi B.V. โ€”
Fabrazyme 5 mg powder for concentrate for solution for infusion
EU/1/01/188/004-006
Protein c agalsidase beta (recombinant human-a-galactoside a) Sanofi B.V. โ€”
Famciclovir 500 mg Film-Coated Tablets
PA2030/001/001
Famciclovir Medinutrix Ltd. Not marketed
Famciclovir Teva 250 mg Film-coated Tablets
PA0749/025/002
Famciclovir Teva Pharma B.V. Marketed
Famotidine Clonmel 20 mg film-coated tablets
PA0126/344/001
Famotidine Clonmel Healthcare Ltd Marketed
Famotidine Clonmel 40 mg film-coated tablets
PA0126/344/002
Famotidine Clonmel Healthcare Ltd Marketed
Famotidine Clonmel Healthcare 20 mg film-coated tablets
PA0126/392/001
Famotidine Clonmel Healthcare Ltd Not marketed
Famotidine Clonmel Healthcare 40 mg film-coated tablets
PA0126/392/002
Famotidine Clonmel Healthcare Ltd Not marketed
Fampridine Accord 10 mg prolonged-release tablets
EU/1/20/1477/001-002
Fampridine Accord Healthcare S.L.U. โ€”
Fampridine Rowa 10 mg prolonged-release tablets
PA0074/087/001
Fampridine Rowa Pharmaceuticals Limited Not marketed
Fampyra 10 mg prolonged-release tablets
EU/1/11/699/001-002
Fampridine Merz Pharmaceuticals GmbH โ€”
Famvir 125 mg film-coated tablets
PA1113/018/001
Famciclovir Phoenix Labs Marketed
Famvir 250 mg film-coated tablets
PA1113/018/002
Famciclovir Phoenix Labs Marketed
Famvir 250 mg film-coated tablets
PPA0465/212/001
Famciclovir PCO Manufacturing Ltd. โ€”
Famvir 250 mg Film-Coated Tablets
PPA1463/166/001
Famciclovir IMED Healthcare Ltd., โ€”
Famvir 500 mg film-coated tablets
PA1113/018/003
Famciclovir Phoenix Labs Marketed
Famvir 500 mg film-coated tablets
PPA0465/212/002
Famciclovir PCO Manufacturing Ltd. โ€”
Famvir 500 mg film-coated tablets
PPA1463/166/002
Famciclovir IMED Healthcare Ltd., โ€”
Fanhdi 1000 IU powder and solvent for solution for injection
PA0849/001/003
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Fanhdi 250 IU powder and solvent for solution for injection
PA0849/001/001
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Fanhdi 500 IU powder and solvent for solution for injection
PA0849/001/002
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Fareston 60 mg Tablets
EU/1/96/004/001
Toremifene citrate Orion Corporation โ€”
Fareston 60 mg Tablets
EU/1/96/004/002
Toremifene Orion Corporation โ€”
Farydak 10 mg hard capsules
EU/1/15/1023/001-003
Panobinostat pharmaand GmbH โ€”
Farydak 15 mg hard capsules
EU/1/15/1023/004-006
Panobinostat pharmaand GmbH โ€”
Farydak 20 mg hard capsules
EU/1/15/1023/007-009
Panobinostat pharmaand GmbH โ€”
Fasenra 30 mg solution for injection
EU/1/17/1252/001-002
Benralizumab AstraZeneca AB โ€”
Faslodex 250 mg Solution for injection
EU/1/03/269/001-002
Fulvestrant AstraZeneca AB โ€”
Fastum 2.5% w/w Gel
PA0512/001/001
Ketoprofen A. Menarini Industrie Farmaceutische Riunite S.r.l. Marketed
Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion
EU/1/00/170/001-002
Rasburicase Sanofi Winthrop Industrie โ€”
Faverin 100 mg film-coated tablets
PA23355/024/002
Fluvoxamine maleate Viatris Healthcare Limited Marketed
Faverin 50 mg film-coated tablets
PA23355/024/001
Fluvoxamine maleate Viatris Healthcare Limited Marketed
Febuxostat Clonmel 120 mg Film-coated tablets
PA0126/295/002
Febuxostat Clonmel Healthcare Ltd Marketed
Febuxostat Clonmel 80 mg Film-coated tablets
PA0126/295/001
Febuxostat Clonmel Healthcare Ltd Marketed
Febuxostat Krka 120 mg film-coated tablets
EU/1/18/1347/005-008
Febuxostat KRKA, d.d., Novo mesto โ€”
Febuxostat Krka 80 mg film-coated tablets
EU/1/18/1347/001-004
Febuxostat KRKA, d.d., Novo mesto โ€”
Febuxostat Rowa 120 mg film-coated tablets
PA0074/085/002
Febuxostat Rowa Pharmaceuticals Limited, โ€”
Febuxostat Rowa 80 mg film-coated tablets
PA0074/085/001
Febuxostat Rowa Pharmaceuticals Limited, โ€”
Febuxostat Rowex 120 mg Film-coated Tablets
PA0711/273/002
Febuxostat Rowex Limited, Marketed
Febuxostat Rowex 80 mg Film-coated Tablets
PA0711/273/001
Febuxostat Rowex Limited, Marketed
Febuxostat Viatris 120 mg film-coated tablets
EU/1/17/1194/009-016
Febuxostat Viatris Limited โ€”
Febuxostat Viatris 80 mg film-coated tablets
EU/1/17/1194/001-008
Febuxostat Viatris Limited โ€”
Fefol Spansule 150 mg/0.5 mg Modified Release Capsules
PA23101/001/001
Dried ferrous sulphate, Folic acid Intapharm Labs Ltd Not marketed
FEIBA 100 U/ml powder and solvent for solution for infusion
PA2004/001/003
Factor VIII inhibitor bypassing fraction Baxalta Innovations GmbH Marketed
FEIBA 50 U/ml powder and solvent for solution for infusion
PA2004/001/002
Feiba Baxalta Innovations GmbH Not marketed
Femara 2.5 mg film-coated tablets
PA0896/012/001
Letrozole Novartis Ireland Limited Not marketed
Femara 2.5 mg film-coated tablets
PPA2306/001/001
Letrozole Originalis B.V. โ€”
Fematab 1mg film-coated tablet
PA22668/015/001
Estradiol hemihydrate Theramex Ireland Limited Marketed
Fematab 2mg Film-coated tablet
PA23355/038/001
Estradiol Viatris Healthcare Limited Marketed
1 2 3 4 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.